27 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
net sales milestone payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing … payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing, and commercial readiness
8-K
EX-1.1
q3rijxwwpll aph
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
tte1naeo
1 Jul 22
Shelf registration
4:13pm
DEF 14A
4gw4if2jj63
28 Apr 22
Definitive proxy
8:36am
424B3
h81u2by67
12 Nov 21
Prospectus supplement
8:41am
424B3
m5xh92c
13 Aug 21
Prospectus supplement
5:25pm
S-4/A
EX-10.8
iuvw9clgzekhp s3uw
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.14
bwjt8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.9
pcj4 r2bajvsmeq
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.12
t5t1zk3
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
8pnn 34si523mqi
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
w39h tcxxkpzj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.15
yvyr r20g6lck
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm